Division of Cardiovascular Medicine, Department of Internal Medicine (C.P.K., K.S., I.T., E.M., R.H., E.T., E.D., K.S.S., T.L.J., J.C.F., J.S., T.C.H., S.G.D.), University of Utah Health and School of Medicine, Salt Lake City.
Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City (C.P.K., I.T., E.M., R.H., E.T., C.H.S., S.G.D.).
Circ Heart Fail. 2024 Sep;17(9):e011358. doi: 10.1161/CIRCHEARTFAILURE.123.011358. Epub 2024 Aug 29.
Cardiogenic shock (CS) can stem from multiple causes and portends poor prognosis. Prior studies have focused on acute myocardial infarction-CS; however, acute decompensated heart failure (ADHF)-CS accounts for most cases. We studied patients suffering ADHF-CS to identify clinical factors, early in their trajectory, associated with a higher probability of successful outcomes.
Consecutive patients with CS were evaluated (N=1162). We studied patients who developed ADHF-CS at our hospital (N=562). Primary end point was native heart survival (NHS), defined as survival to discharge without receiving advanced HF therapies. Secondary end points were adverse events, survival, major cardiac interventions, and hospital readmissions within 1 year following index hospitalization discharge. Association of clinical data with NHS was analyzed using logistic regression.
Overall, 357 (63.5%) patients achieved NHS, 165 (29.2%) died, and 41 (7.3%) were discharged post advanced HF therapies. Of 398 discharged patients (70.8%), 303 (53.9%) were alive at 1 year. Patients with NHS less commonly suffered cardiac arrest, underwent intubation or pulmonary artery catheter placement, or received temporary mechanical circulatory support, had better hemodynamic and echocardiographic profiles, and had a lower vasoactive-inotropic score at shock onset. Bleeding, hemorrhagic stroke, hemolysis in patients with mechanical circulatory support, and acute kidney injury requiring renal replacement therapy were less common compared with patients who died or received advanced HF therapies. After multivariable adjustments, clinical variables associated with NHS likelihood included younger age, history of systemic hypertension, absence of cardiac arrest or acute kidney injury requiring renal replacement therapy, lower pulmonary capillary wedge pressure and vasoactive-inotropic score, and higher tricuspid annular plane systolic excursion at shock onset (all <0.05).
By studying contemporary patients with ADHF-CS, we identified clinical factors that can inform clinical management and provide future research targets. Right ventricular function, renal function, pulmonary artery catheter placement, and type and timing of temporary mechanical circulatory support warrant further investigation to improve outcomes of this devastating condition.
心原性休克(CS)可由多种原因引起,并预示预后不良。先前的研究集中在急性心肌梗死-CS;然而,急性失代偿性心力衰竭(ADHF)-CS 占大多数病例。我们研究了患有 ADHF-CS 的患者,以确定在病程早期与更高成功率相关的临床因素。
评估了连续的 CS 患者(N=1162)。我们研究了在我们医院发生 ADHF-CS 的患者(N=562)。主要终点是原生心脏存活率(NHS),定义为在不接受高级 HF 治疗的情况下出院时的存活率。次要终点是 1 年内索引住院出院后的不良事件、存活率、主要心脏介入和医院再入院。使用逻辑回归分析临床数据与 NHS 的相关性。
总体而言,357 名(63.5%)患者实现了 NHS,165 名(29.2%)死亡,41 名(7.3%)在接受高级 HF 治疗后出院。在 398 名出院患者中(70.8%),303 名(53.9%)在 1 年内存活。NHS 患者较少发生心脏骤停、气管插管或肺动脉导管放置或接受临时机械循环支持,具有更好的血流动力学和超声心动图特征,在休克发作时血管活性-正性肌力评分较低。与死亡或接受高级 HF 治疗的患者相比,出血、出血性中风、机械循环支持患者的溶血以及需要肾脏替代治疗的急性肾损伤较少见。多变量调整后,与 NHS 可能性相关的临床变量包括年龄较小、有系统性高血压病史、无心脏骤停或需要肾脏替代治疗的急性肾损伤、较低的肺动脉楔压和血管活性-正性肌力评分,以及较高的三尖瓣环平面收缩期位移在休克发作时(均<0.05)。
通过研究当代 ADHF-CS 患者,我们确定了可以为临床管理提供信息并为未来研究提供目标的临床因素。右心室功能、肾功能、肺动脉导管放置以及临时机械循环支持的类型和时机需要进一步研究,以改善这种毁灭性疾病的预后。